Axiom Investors LLC DE Sells 66,003 Shares of Hamilton Lane Inc. $HLNE

Key Points

• Axiom Investors LLC has reduced its holdings in Hamilton Lane Inc. by 57.3%, now owning approximately 0.09% of the company, valued at $7.3 million.
• Several institutional investors increased their stakes in Hamilton Lane, including Ensign Peak Advisors which lifted its stake by 78.4% during the fourth quarter.
• Hamilton Lane announced a quarterly dividend of $0.54 per share, translating to an annualized yield of 1.5% and a current payout ratio of 41.54%.

Axiom Investors LLC DE lowered its stake in Hamilton Lane Inc. (NASDAQ:HLNE - Free Report) by 57.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 49,102 shares of the company's stock after selling 66,003 shares during the quarter. Axiom Investors LLC DE owned approximately 0.09% of Hamilton Lane worth $7,300,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of HLNE. Kayne Anderson Rudnick Investment Management LLC acquired a new stake in shares of Hamilton Lane in the first quarter valued at about $432,772,000. Champlain Investment Partners LLC acquired a new stake in shares of Hamilton Lane in the first quarter valued at about $112,887,000. T. Rowe Price Investment Management Inc. increased its position in shares of Hamilton Lane by 63.4% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,275,000 shares of the company's stock valued at $189,555,000 after acquiring an additional 494,637 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Hamilton Lane in the first quarter valued at about $24,334,000. Finally, GAMMA Investing LLC increased its position in shares of Hamilton Lane by 24,544.3% in the first quarter. GAMMA Investing LLC now owns 136,776 shares of the company's stock valued at $203,340,000 after acquiring an additional 136,221 shares during the last quarter. Institutional investors and hedge funds own 97.40% of the company's stock.

Hamilton Lane Stock Performance

Shares of NASDAQ:HLNE traded down $5.01 during trading on Friday, reaching $148.79. 299,411 shares of the stock were exchanged, compared to its average volume of 351,623. Hamilton Lane Inc. has a 12 month low of $124.10 and a 12 month high of $203.72. The firm has a market cap of $8.28 billion, a PE ratio of 28.61 and a beta of 1.26. The stock has a 50-day moving average price of $152.69 and a 200-day moving average price of $150.63. The company has a current ratio of 4.32, a quick ratio of 4.32 and a debt-to-equity ratio of 0.29.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.98 by $0.33. Hamilton Lane had a return on equity of 29.47% and a net margin of 30.66%.The company had revenue of $196.73 million during the quarter, compared to analysts' expectations of $166.96 million. During the same quarter in the previous year, the company posted $1.47 earnings per share. The business's revenue was up 11.8% on a year-over-year basis. Research analysts expect that Hamilton Lane Inc. will post 4.97 EPS for the current fiscal year.

Hamilton Lane Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 6th. Stockholders of record on Friday, September 19th will be issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Friday, September 19th. Hamilton Lane's payout ratio is currently 41.54%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. JPMorgan Chase & Co. lowered their price target on Hamilton Lane from $153.00 to $145.00 and set a "neutral" rating on the stock in a research report on Wednesday, July 23rd. Wall Street Zen raised Hamilton Lane from a "sell" rating to a "hold" rating in a research report on Saturday, August 9th. Keefe, Bruyette & Woods boosted their price target on Hamilton Lane from $160.00 to $168.00 and gave the stock a "market perform" rating in a research report on Wednesday, August 6th. Finally, Wells Fargo & Company boosted their price target on Hamilton Lane from $161.00 to $162.00 and gave the stock an "equal weight" rating in a research report on Friday, July 11th. Six analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Reduce" and an average target price of $163.14.

Insider Activity

In related news, major shareholder River 5 Ltd French sold 150,000 shares of the business's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $146.51, for a total value of $21,976,500.00. Following the completion of the sale, the insider directly owned 330,015 shares in the company, valued at approximately $48,350,497.65. The trade was a 31.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 22.21% of the company's stock.

Hamilton Lane Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.